Top Scandinavian companies are boycotting the maker of Oreo and Toblerone for its business in RussiaByDiego LasartePublishedJune 12, 2023
Chinese media are celebrating Elon Musk’s Beijing visit as a much-needed vote of confidenceByMary HuiPublishedMay 31, 2023
Insurance coverage for Ozempic shows the complexity of obesity treatmentByAnnalisa MerelliPublishedMay 29, 2023
Guess how much big pharma paid in US taxes on $110 billion of profit in 2022ByAnnalisa MerelliPublishedMay 17, 2023
Pfizer's RSV vaccine promise to the Global South is already several years behind scheduleByAnnalisa MerelliPublishedMay 7, 2023
Sunday Reads: BP shareholders revolt, Starship’s dust settles, swan factsByJulia MalleckPublishedApril 30, 2023
How to make sense of the new CDC guidelines on covid vaccine boosters for childrenByAnnalisa MerelliPublishedApril 25, 2023
Merck is paying $10.8 billion for a company with no approved drugsByAnanya BhattacharyaPublishedApril 17, 2023
As Covid-19 shot sales dwindle, BioNTech doubles down on cancer vaccinesByAnnalisa MerelliUpdatedMarch 27, 2023
